Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging

J Biomed Nanotechnol. 2010 Aug;6(4):375-84. doi: 10.1166/jbn.2010.1132.

Abstract

The gastrin releasing peptide-receptor (GRP-r) is over-expressed in breast and prostate cancer and lymph node metastases. Lys3-bombesin is a peptide that binds with high affinity to GRP-r. The aim of this research was to prepare a multifunctional system of technetium-99m labelled gold nanoparticles conjugated to Lys3-bombesin/HYNIC-GGC and to evaluate its biological behaviour as a potential radiopharmaceutical for in vivo GRP-r imaging.

Methods: Lys3-bombesin and hydrazinonicotinamide-Gly-Gly-Cys-NH2 (HYNIC-GGC) peptides were conjugated to gold nanoparticles (AuNP, 20 nm) to prepare a multifunctional system of HYNIC-GGC-AuNP-Lys3-bombesin by means of spontaneous reaction of the thiol (Cys) present in HYNIC-GGC sequence and the amine of Lys3-bombesin. The nanoconjugate was characterized by transmission electron microscopy (TEM), IR, UV-Vis, Raman, and X-ray photoelectron spectroscopy (XPS). Technetium-99m labelling through the HYNIC-GGC ligand was carried out using EDDA/tricine as coligands and SnCl2 as reducing agent with further size exclusion chromatography purification. Radiochemical purity was determined by size exclusion HPLC and ITLC-SG analyses. In vitro binding studies were carried out in human prostate cancer PC-3 cells (GRP-r positive cells). Biodistribution studies were accomplished in athymic mice with PC-3 induced tumours and images obtained using a micro-SPECT/CT system.

Results: TEM and spectroscopy techniques demonstrated that AuNPs were functionalized with HYNIC-GGC-NH2 and Lys3-bombesin through interactions with thiol groups of Cysteine and the N-terminal and epsilon-amine of Lysine respectively. Radio-chromatograms showed radiochemical purity higher than 95%. 99mTc-EDDA/HYNIC-GGC-AuNP-Lys3-bombesin (99mTc-AuNP-Lys3-bombesin) showed specific recognition for GRP-r over-expressed in PC-3 cells. After administration of 99mTc-AuNP-Lys3-bombesin in mice the pancreas-to-blood ratio was 36 at 1 h demonstrating ability to target in vivo GRP receptor-bearing cells. In vivo micro-SPECT/CT images in mice showed an evident tumour uptake (6.39 +/- 0.83% IA/g at 1 h).

Conclusions: This study demonstrated that the 99mTc-AuNP-Lys3-bombesin multifunctional system shows specific recognition for GRP-r and suitable properties to be used as a molecular imaging agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Gold*
  • Male
  • Metal Nanoparticles*
  • Mice
  • Mice, Nude
  • Microscopy, Electron, Transmission
  • Molecular Structure
  • Nanoconjugates* / chemistry
  • Organotechnetium Compounds
  • Prostatic Neoplasms / diagnosis
  • Radionuclide Imaging*
  • Radiopharmaceuticals
  • Receptors, Bombesin / chemistry*
  • Spectrophotometry, Infrared
  • Technetium*

Substances

  • Nanoconjugates
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • Receptors, Bombesin
  • Technetium
  • Gold